Stock RNAZ TRANSCODE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. TransCode Therapeutics, Inc.

Equities

RNAZ

US89357L3033

Delayed Nasdaq
Other stock markets
 20:46:55 06/05/2024 BST 		5-day change 1st Jan Change
0.8299 USD +1.21% Intraday chart for TransCode Therapeutics, Inc. +41.38% -87.41%
04-22 Certain Warrants of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-APR-2024. CI
04-22 Certain Stock Options of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-APR-2024. CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates
MT
US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision
MT
Traders Stay Cautious Ahead of Fed Rate Decision, Weighing on US Equity Futures
MT
HC Wainwright Adjusts Price Target on TransCode Therapeutics to $6 From $10, Maintains Buy Rating
MT
HC Wainwright Starts TransCode Therapeutics at Buy With $10 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RNAZ Stock
  4. News TransCode Therapeutics, Inc.
  5. Analyst Reco.